TGFB1 and neoplasm: These include the downregulation of tumor antigens to reduce detection by T-cells, the secretion of immunosuppressive molecules such as TGF-β and IL-10 that create a hostile environment for immune cells, and the manipulation of immune checkpoints to inhibit T-cell activation.